Thomas E. Carey

71.0k total citations · 3 hit papers
328 papers, 14.1k citations indexed

About

Thomas E. Carey is a scholar working on Molecular Biology, Oncology and Otorhinolaryngology. According to data from OpenAlex, Thomas E. Carey has authored 328 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Molecular Biology, 125 papers in Oncology and 99 papers in Otorhinolaryngology. Recurrent topics in Thomas E. Carey's work include Head and Neck Cancer Studies (92 papers), Cancer-related Molecular Pathways (33 papers) and Head and Neck Surgical Oncology (33 papers). Thomas E. Carey is often cited by papers focused on Head and Neck Cancer Studies (92 papers), Cancer-related Molecular Pathways (33 papers) and Head and Neck Surgical Oncology (33 papers). Thomas E. Carey collaborates with scholars based in United States, Japan and Finland. Thomas E. Carey's co-authors include Carol R. Bradford, Gregory T. Wolf, Mark E. Prince, Douglas B. Chepeha, Jonathan B. McHugh, Avraham Eisbruch, Francis P. Worden, Nisha J. D’Silva, Kenneth D. McClatchey and Bhavna Kumar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Thomas E. Carey

325 papers receiving 13.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer

2008 608 citations Thomas E. Carey et al. profile →
EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer

2008 493 citations Francis P. Worden, Mark E. Prince et al. Journal of Clinical Oncology profile →
Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

1976 376 citations Thomas E. Carey et al. profile →

Peers

Countries citing papers authored by Thomas E. Carey

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Carey more than expected).

Fields of papers citing papers by Thomas E. Carey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Carey. The network helps show where Thomas E. Carey may publish in the future.

Co-authorship network of co-authors of Thomas E. Carey

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Carey. A scholar is included among the top collaborators of Thomas E. Carey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Carey. Thomas E. Carey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Lack of the human choline transporter‐like protein SLC44A2 causes hearing impairment and a rare red blood phenotype 2023 ·EMBO Molecular Medicine ·Bérengère Koehl, Cédric Vrignaud, (unknown), Thankam Nair, (unknown), (unknown), (unknown), (unknown), (unknown), Hanane El Kenz, Olivier Hermine, Narla Mohandas, Jean‐Pierre Cartron, Yves Colin, Olivier Detante, Raphaël Marlu, Caroline Le Van Kim, Thomas E. Carey, Slim Azouzi, Thierry Peyrard	6
2	Incidence and clearance of oral and cervicogenital HPV infection: longitudinal analysis of the MHOC cohort study 2022 ·BMJ Open ·Andrew F. Brouwer, (unknown), Heather M. Walline, (unknown), (unknown), (unknown), (unknown), Yan Kwan Lau, E. Cowles Andrus, Thankam Nair, Thomas E. Carey, Marisa C. Eisenberg, Rafael Meza	12
3	The choline transporter Slc44a2 controls platelet activation and thrombosis by regulating mitochondrial function 2020 ·Nature Communications ·(unknown), Michael A. Mastrangelo, Sara Ture, Charles O. Smith, (unknown), (unknown), Xu Shi, Ryan M. Burke, Sherry L. Spinelli, Scott J. Cameron, Thomas E. Carey, Paul S. Brookes, Robert E. Gerszten, Maria Sabater‐Lleal, Paul S. de Vries, Jennifer E. Huffman, Nicholas L. Smith, Craig N. Morrell, Charles J. Lowenstein	56
4	Targeting the MET Receptor Tyrosine Kinase as a Strategy for Radiosensitization in Locoregionally Advanced Head and Neck Squamous Cell Carcinoma 2019 ·Molecular Cancer Therapeutics ·Lluís Nisa, Paola Francica, Roland Giger, Matúš Medo, Olgun Eliçin, Manja Friese‐Hamim, Claudia Wilm, Christopher Stroh, Beat Bojaxhiu, (unknown), Marco Caversaccio, Matthias S. Dettmer, (unknown), Tess M. Brodie, Daniel M. Aebersold, Yitzhak Zimmer, Thomas E. Carey, Michaela Medová	11
5	Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite Vaccine 2018 ·Clinical Cancer Research ·Yee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, Christopher R. Donnelly, Xiaobo Luo, Blake R. Heath, Xinyi Zhao, Emily L. Bellile, Hongxiang Hu, Hongwei Chen, Peter J. Polverini, Qianming Chen, Simon Young, Thomas E. Carey, Jacques E. Nör, Robert L. Ferris, Gregory T. Wolf, Duxin Sun, Yu L. Lei	124
6	Comprehensive Genomic Profiling of Patient-matched Head and Neck Cancer Cells: A Preclinical Pipeline for Metastatic and Recurrent Disease 2018 ·Molecular Cancer Research ·Lluís Nisa, David Barras, Michaela Medová, Daniel M. Aebersold, Matúš Medo, (unknown), (unknown), Beat Bojaxhiu, Olgun Eliçin, Matthias S. Dettmer, Paolo Angelino, Roland Giger, Urs Borner, Marco Caversaccio, Thomas E. Carey, Liza Ho, Thomas McKee, Mauro Delorenzi, Yitzhak Zimmer	23
7	Dynamics and Determinants of HPV Infection: The Michigan HPV and Oropharyngeal Cancer (M-HOC) Study 2018 ·BMJ Open ·Marisa C. Eisenberg, (unknown), Andrew F. Brouwer, Heather M. Walline, (unknown), Yan Kwan Lau, (unknown), (unknown), (unknown), (unknown), (unknown), Thomas E. Carey, Rafael Meza	9
8	HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers 2017 ·Molecular Cancer Research ·Lada A. Koneva, Yanxiao Zhang, Shama Virani, (unknown), Jonathan B. McHugh, Douglas B. Chepeha, Gregory T. Wolf, Thomas E. Carey, Laura S. Rozek, Maureen A. Sartor	147
9	Distinct pattern of TP53 mutations in human immunodeficiency virus–related head and neck squamous cell carcinoma 2017 ·Cancer ·Frederico O. Gleber‐Netto, Mei Zhao, Sanchit Trivedi, Jiping Wang, Samar A. Jasser, (unknown), Humam Kadara, Jiexin Zhang, Jing Wang, William N. William, J. Jack Lee, Minh Ly Nguyen, Sara I. Pai, Heather M. Walline, Dong M. Shin, Robert L. Ferris, Thomas E. Carey, Jeffrey N. Myers, Curtis R. Pickering	18
10	Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma 2016 ·Molecular Cancer Research ·Heather M. Walline, Christine M. Komarck, Jonathan B. McHugh, Emily L. Bellile, J. Chad Brenner, Mark E. Prince, Erin L. McKean, Douglas B. Chepeha, Gregory T. Wolf, Francis P. Worden, Carol R. Bradford, Thomas E. Carey	41
11	Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures 2016 ·Clinical Cancer Research ·Yanxiao Zhang, Lada A. Koneva, Shama Virani, Anna E. Arthur, (unknown), (unknown), Charles Warden, Thomas E. Carey, Douglas B. Chepeha, Mark E. Prince, Jonathan B. McHugh, Gregory T. Wolf, Laura S. Rozek, Maureen A. Sartor	110
12	Prevention of Tumor Growth Driven by PIK3CA and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3 2015 ·Cancer Prevention Research ·(unknown), Lynn Vitale‐Cross, Daniel Martı́n, Abraham Schneider, Alfredo Molinolo, Nitin Gangane, Thomas E. Carey, Jonathan B. McHugh, Christine M. Komarck, Heather M. Walline, William N. William, Raja R. Seethala, Robert L. Ferris, J. Silvio Gutkind	48
13	High-Frequency Targetable EGFR Mutations in Sinonasal Squamous Cell Carcinomas Arising from Inverted Sinonasal Papilloma 2015 ·Cancer Research ·Aaron M. Udager, Delphine Rolland, Jonathan B. McHugh, Bryan L. Betz, Carlos Murga‐Zamalloa, Thomas E. Carey, Lawrence J. Marentette, Mario Hermsen, (unknown), Megan S. Lim, Kojo S.J. Elenitoba‐Johnson, Noah A. Brown	97
14	Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites 2011 ·Clinical Cancer Research ·Mei Zhao, Daisuke Sano, Curtis R. Pickering, Samar A. Jasser, Ying C. Henderson, Gary L. Clayman, Erich M. Sturgis, Thomas J. Ow, Reuben Lotan, Thomas E. Carey, Peter G. Sacks, Jennifer R. Grandis, David Sidransky, (unknown), Jeffrey N. Myers	224
15	Intensity-Modulated Chemoradiotherapy Aiming to Reduce Dysphagia in Patients With Oropharyngeal Cancer: Clinical and Functional Results 2010 ·Journal of Clinical Oncology ·Felix Y. Feng, Hyungjin Myra Kim, Teresa Lyden, Marc J. Haxer, Francis P. Worden, Mary Feng, Jeffrey S. Moyer, Mark E. Prince, Thomas E. Carey, Gregory T. Wolf, Carol R. Bradford, Douglas B. Chepeha, Avraham Eisbruch	261
16	Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer 2008 ·Molecular Cancer Therapeutics ·Sanjeev Shangary, Ke Ding, Su Qiu, Zaneta Nikolovska‐Coleska, Joshua A. Bauer, Meilan Liu, Guoping Wang, Yipin Lu, Donna McEachern, Denzil Bernard, Carol R. Bradford, Thomas E. Carey, Shaomeng Wang	75
17	Epigenetic Inactivation of Galanin Receptor 1 in Head and Neck Cancer 2008 ·Clinical Cancer Research ·Kiyoshi Misawa, Yo Ueda, Takeharu Kanazawa, Yuki Misawa, (unknown), (unknown), Tetsuya Ogawa, Satoru Takebayashi, Reidar Grénman, James G. Herman, Hiroyuki Mineta, Thomas E. Carey	56
18	A Novel BH3 Mimetic Reveals a Mitogen-Activated Protein Kinase–Dependent Mechanism of Melanoma Cell Death Controlled by p53 and Reactive Oxygen Species 2006 ·Cancer Research ·Monique Verhaegen, Joshua A. Bauer, Cristina Martín de la Vega, Guoping Wang, Keith G. Wolter, (unknown), Zaneta Nikolovska‐Coleska, (unknown), Rajan P. Nair, James T. Elder, (unknown), Thomas E. Carey, Carol R. Bradford, Shaomeng Wang, Marı́a S. Soengas	117
19	Bridging the gap: Health disparity research initiatives through the department of defense (DOD) congressionally directed medical research programs (CDMRP) prostate cancer research program (PCRP) 2005 ·Cancer Research ·(unknown), Thomas E. Carey, Jean B. deKernion, Robert Dreicer, Monica Liebert, Douglas L. Miller, Geert Prins, (unknown), Mack Roach, Howard R. Soule, Jeffrey A. Smith, Nicholas J. Vogelzang, Frederic M. Waldman, (unknown), (unknown), (unknown), Talia Miller, (unknown), Jordana Bernard, (unknown)	4
20	Radioimmunodiagnosis of Human-Derived Squamous Cell Carcinoma 1987 ·Hybridoma ·Richard L. Wahl, Kathryn A. Kimmel, William H. Beierwaltes, Thomas E. Carey	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact